Literature DB >> 27671491

Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects.

Samuel J Jurca1, William J Elliott2.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to highlight common or important substances or habits that elevate blood pressure and offer suggestions, based on recent literature, to limit their use or effects. RECENT
FINDINGS: Despite decades of advice to the general populace from public health authorities to avoid or reduce dietary sodium and non-steroidal anti-inflammatory drug (NSAID) use, more evidence has accumulated from nationwide surveys, clinical trials, and pathophysiological or mechanistic studies that show how important these modalities can (and should) be for hypertensive and prehypertensive individuals and the general population. Other common stimuli that increase blood pressure can be divided into many that are easily avoided (e.g., phenethylamines, anabolic steroids), those that must be continued for important medical reasons (e.g., erythropoietin, tyrosine kinase inhibitors) and therefore require intensified antihypertensive therapy, and a few (e.g., glucocorticoids, hormonal contraceptives) that fall between these two paradigms.

Entities:  

Keywords:  Blood pressure; Drug-induced hypertension; Resistant hypertension; Secondary hypertension

Mesh:

Substances:

Year:  2016        PMID: 27671491     DOI: 10.1007/s11906-016-0682-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  49 in total

1.  Too much of a good thing: a woman with hypertension and hypokalemia.

Authors:  Sean C Murphy; Sean Agger; Petrie M Rainey
Journal:  Clin Chem       Date:  2009-12       Impact factor: 8.327

2.  Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.

Authors:  Gérard Zalcman; Julien Mazieres; Jacques Margery; Laurent Greillier; Clarisse Audigier-Valette; Denis Moro-Sibilot; Olivier Molinier; Romain Corre; Isabelle Monnet; Valérie Gounant; Frédéric Rivière; Henri Janicot; Radj Gervais; Chrystèle Locher; Bernard Milleron; Quan Tran; Marie-Paule Lebitasy; Franck Morin; Christian Creveuil; Jean-Jacques Parienti; Arnaud Scherpereel
Journal:  Lancet       Date:  2015-12-21       Impact factor: 79.321

3.  Recreational phenethylamine poisonings reported to a French poison control center.

Authors:  Gaël Le Roux; Chloé Bruneau; Bénédicte Lelièvre; Marie Bretaudeau Deguigne; Alain Turcant; Patrick Harry; David Boels
Journal:  Drug Alcohol Depend       Date:  2015-07-03       Impact factor: 4.492

4.  RETRACTED: Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis.

Authors:  Bruno R da Costa; Stephan Reichenbach; Noah Keller; Linda Nartey; Simon Wandel; Peter Jüni; Sven Trelle
Journal:  Lancet       Date:  2016-03-18       Impact factor: 79.321

5.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

6.  Liquorice-induced hypertension--a new understanding of an old disease: case report and brief review.

Authors:  J Heikens; E Fliers; E Endert; M Ackermans; G van Montfrans
Journal:  Neth J Med       Date:  1995-11       Impact factor: 1.422

7.  Cardiovascular risk and events in 17 low-, middle-, and high-income countries.

Authors:  Salim Yusuf; Sumathy Rangarajan; Koon Teo; Shofiqul Islam; Wei Li; Lisheng Liu; Jian Bo; Qinglin Lou; Fanghong Lu; Tianlu Liu; Liu Yu; Shiying Zhang; Prem Mony; Sumathi Swaminathan; Viswanathan Mohan; Rajeev Gupta; Rajesh Kumar; Krishnapillai Vijayakumar; Scott Lear; Sonia Anand; Andreas Wielgosz; Rafael Diaz; Alvaro Avezum; Patricio Lopez-Jaramillo; Fernando Lanas; Khalid Yusoff; Noorhassim Ismail; Romaina Iqbal; Omar Rahman; Annika Rosengren; Afzalhussein Yusufali; Roya Kelishadi; Annamarie Kruger; Thandi Puoane; Andrzej Szuba; Jephat Chifamba; Aytekin Oguz; Matthew McQueen; Martin McKee; Gilles Dagenais
Journal:  N Engl J Med       Date:  2014-08-28       Impact factor: 91.245

8.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

Review 9.  Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources.

Authors:  Marcos Antonio Pereira dos Santos; Caio Victor Coutinho de Oliveira; Alexandre Sérgio Silva
Journal:  Subst Use Misuse       Date:  2014-05-15       Impact factor: 2.164

Review 10.  Hypertension in patients with cancer.

Authors:  Vinicius Barbosa de Souza; Eduardo Nani Silva; Mario Luiz Ribeiro; Wolney de Andrade Martins
Journal:  Arq Bras Cardiol       Date:  2015-02-27       Impact factor: 2.000

View more
  3 in total

1.  Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.

Authors:  Andrew Y Hwang; Chintan V Dave; Steven M Smith
Journal:  Am J Hypertens       Date:  2018-11-13       Impact factor: 2.689

2.  Antenatal exposure to nonsteroidal anti-inflammatory drugs and risk of neonatal hypertension.

Authors:  Mounira Habli; Corey C Clifford; Tammy M Brady; Zahidee Rodriguez; Michaela Eschenbacher; Malcolm Wu; Emily DeFranco; James Gresh; Beena D Kamath-Rayne
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-27       Impact factor: 3.738

3.  Obesity as an effect modifier of the association between menstrual abnormalities and hypertension in young adult women: Results from Project ELEFANT.

Authors:  Hui Xu; Peng-Hui Li; Timothy M Barrow; Elena Colicino; Changping Li; Ruixue Song; Hongbin Liu; Nai-Jun Tang; Songyan Liu; Liqiong Guo; Hyang-Min Byun
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.